Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

The Asan Foundation patents


Recent patent applications related to The Asan Foundation. The Asan Foundation is listed as an Agent/Assignee. Note: The Asan Foundation may have other listings under different names/spellings. We're not affiliated with The Asan Foundation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | The Asan Foundation-related inventors


Hybrid stent

A hybrid stent includes multiple main cells aligned in a spiral shape and including multiple first link units which are aligned diagonally and spaced at a predetermined distance from each other and multiple second link units which connect adjacent first link units among the multiple first link units and are spaced at a predetermined distance from each other, and one or more open cells adjacent to the multiple main cells in a longitudinal direction and aligned in a spiral shape.. . ... The Asan Foundation

Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient

The present disclosure relates to a composition for preventing or treating metabolic diseases, in which the composition includes bacteroides acidifaciens as an active ingredient. In addition, the present disclosure relates to a composition for oxidizing fat or inhibiting dpp-4, in which the composition includes bacteroides acidifaciens as an active ingredient. ... The Asan Foundation

Novel biomarker for predicting sensitivity to met inhibitor, and use thereof

The present invention relates to a novel biomarker for predicting susceptibility to an met inhibitor, and a use thereof, and more specifically, the present invention provides: a biomarker for predicting susceptibility to the met inhibitor, the biomarker comprising the immunoglobulin superfamily member 1 (igsf1, nm_001555.2) gene; a composition for predicting susceptibility to the met inhibitor, the composition comprising a pharmaceutical preparation for measuring the degree of expression of the gene in the biomarker, or the degree of expression of the protein of the gene; a pharmaceutical composition for treating diseases related to the dysregulation of the met signaling pathway, the pharmaceutical composition comprising, as an active ingredient, an inhibitor inhibiting the expression of the gene in the biomarker, or the expression or activity of the protein of the gene; a kit for predicting susceptibility to the met inhibitor, the kit comprising the compositions; and a method for predicting susceptibility to the met inhibitor. According to the present invention, the present invention has an excellent effect of predicting susceptibility to the met inhibitor for stomach cancer or lung cancer, and thus the present invention may be usefully employed for treating stomach cancer or lung cancer.. ... The Asan Foundation

Method for preparing organic fluoride-aliphatic compound and method for purifying organic fluoride-aliphatic compound

A method for preparing a radiopharmaceutical and, specifically, a method for preparing an organic fluoride-aliphatic compound usable as a radiopharmaceutical, a method for purifying the prepared organic fluoride-aliphatic compound, and a method for preparing a radiopharmaceutical by using a cassette comprising a backdraft preventing reaction container. A method for preparing an organic fluorinated aliphatic compound includes allowing a fluorine salt to react with a leaving group-containing aliphatic compound by using a multifunctional solvent represented by the following chemical formula 1 to obtain an aliphatic compound labeled with [18f] fluoride substituting for the leaving group. ... The Asan Foundation

Composition for preventing or treating obesity containing alpha-lipoic acid and n-acetylcysteine as active ingredients

The present invention provides a composition containing α-lipoic acid and n-acetylcysteine as active ingredients. The mixed composition of α-lipoic acid and n-acetylcysteine of the present invention can reduce a risk of side effects due to drugs with synergetic effects due to merge administration of two drugs, and can be usefully used for preventing or treating obesity with excellent effects of inhibiting a weight gain compared to each single composition containing α-lipoic acid or n-acetylcysteine.. ... The Asan Foundation

Tumor surface dose enhancing radiotherapy apparatus using magnetic field

Disclosed is a tumor surface dose enhancing radiotherapy apparatus using a magnetic field, including a radiation beam generating unit that irradiates a radiation beam towards a tumor of a patient, a magnetic field generating unit that forms a magnetic field that is parallel to the radiation beam between the radiation beam generating unit and the tumor of the patient, and a control unit that controls a surface dose of the tumor by adjusting an intensity and an effective area of the magnetic field of the magnetic field generating unit.. . ... The Asan Foundation

Method for generating insertion trajectory of surgical needle

The present disclosure relates to a method for generating an insertion trajectory of a surgical needle from an entry point to a target, including the steps of: preparing a medical image including the target and an anatomical structure; and extracting an insertion trajectory in consideration of at least one of a degree of invasion into the anatomical structure through the insertion trajectory and a distance of the insertion trajectory. Further, the present disclosure relates to a method for generating an insertion trajectory of a medical device, and a robot for interventional procedures including needle insertion.. ... The Asan Foundation








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with The Asan Foundation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for The Asan Foundation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###